A systematic review of mirtazapine treatment trials has found that there is inadequate reporting of adverse events in therapeutic trials of major depression (Watanabe et al. CNS Drugs 2010; 24: 35-53).
It takes 30 seconds or login using your email address
Please enter the email address that you registered the newsletter with
